题名

Effects of Parathyroid Hormone on Plasma Zinc Concentration in Rat with Chronic Renal Failure

作者

Shu-Ming Chen;Cheng-Deng Kuo;Jyh-Fei Liao;Low-Tone Ho

关键词

parathyroid hormone ; hypozincemia ; chronic renal failure ; metallothionein ; secondary hyperparathyroidism

期刊名称

The Chinese Journal of Physiology

卷期/出版年月

48卷3期(2005 / 09 / 30)

页次

121 - 128

内容语文

英文

英文摘要

Although both secondary hyperparathyroidism (HPT) and hypozincemia are commonly observed in humans and animals with chronic renal failure (CRF), the relationship between secondary HPT and hypozincemia is little delineated. The present study was designed to examine whether the elevated plasma parathyroid hormones (PTH) levels do affect the disposition of extrarenal zinc and decrease plasma zinc level in CRF rats. The experiment was performed in normal and CRF rats with intact parathyroid gland and parathyroidectomized (PTX), using an acute zinc load alone or in combination with PTH infusion in five groups of rats: normal control, CRF control, CRF+PTH, CRF+PTX and CRF+PTX+PTH. Five sixths nephrectomy was used to produce CRF. All rats were infused with 0.05 mg/kg/min ZnSO4 alone or in combination with 10 μg/kg/min PTH through intravenous infusion for 90 min with serial monitoring of plasma zinc levels every 30 min. The alteration of plasma interleukin-6 (IL-6) levels and the effect of zinc levels in red blood cells (RBCs), as well as the output of bile juice zinc and urinary zinc excretion during the 90-min infusion were also examined. After 90-min infusion, liver tissue was harvested to determine its contents of zinc and metallothionein (MT). During zinc sulfate infusion, the responses of plasma zinc concentration in PTH-combined infusion groups markedly decreased as compared with those of the non-PTH-combined infusion groups, especially in the CRF rats with PTX. However, when zinc sulfate alone was infused, the response of plasma zinc concentration was found to increase in CRF rats with PTX as compared with that of the CRF control rats. PTH infusion groups significantly increased the levels of plasma IL-6 (P<0.05), but it did not alter the levels of RBC zinc and the secretion of bile zinc during the 90-min infusion. After 90-min zinc sulfate infusion, higher liver zinc and MT contents were found in CRF control, CRF+PTH and CRF+PTX+PTH rats, but was not found in the CRF+PTX rats. Zinc sulfate infused alone was found to increase the excretion of basal zinc in bile juice and urine, in both normal and CRF rats. The percentage of zinc load translocated out from the plasma during 90-min zinc sulfate infusion significantly rises in CRF rats and CRF rats with PTH combined infusion as compared with normal control rats. However, in CRF rats with PTX, the percentage of zinc load translocated out from plasma during 90-mm zinc sulfate infusion was similar to that in the normal control rats. Therefore, we suggested that in CRF rats, the excessive secretion of PTH may play a role in the pathogenesis of hypozincemia because PTH enhanced extrarenal zinc disposal.

主题分类 醫藥衛生 > 基礎醫學
参考文献
  1. Abu-Hamdan, D.K.,Mahajan, S.K.,Migdal, S.D.,Prasad, A.S.,McDonald, F.D.,Park, A.,Michigan, D.(1986).Zinc tolerance test in uremia.Ann. Intern. Med.,104,50-52.
  2. Atkin-Thor, E.,Goddard, B.,O`Nion, J.,Stephen, R.L.,Kolff, W.J.(1978).Hypogeusia and zine depletion in chronic dialysis patients.Am. J. Clin. Nutr.,31,1948-1951.
  3. Berg, J.M.,Shi, Y.(1996).The galvanization of biology: A growing appreciation for the roles of zinc.Science,271,1081-1085.
  4. Blendis, L.M.,Ampil, M.,Wilson, D.R.,Kiwan, J.,Labranche, J.,Johnson, M.,Williams, C.(1981).The importance of dietary protein in the zinc deficiency of uremia.Am. I. Clin. Nutr.,34,2658-2661.
  5. Bogin, E.,Massry, S.G.,Harary, I.(1981).Effect of parathyroid hormone on rat heart cells.J. Clin. Invest.,67,1215-1227.
  6. Borle, A.B.(1968).Calcium metabolism in Hella cells and the effect of parathyroid hormone.J. Cell. Biol,36,567-582.
  7. Bremner, I.(1991).Nutritional and physiologic significance of metallothionein.Method Enzymol,205,25-35.
  8. Bremner, I.,Hoekstra, W.G.,Davies, N.T.,Young, B.W.(1978).Effect of zinc status of rats on the synthesis and degradation of copper-induced metallothionein.Biochem. J.,174,883-892.
  9. Chausmer, A.B.,Sherman, B.S.,Wallach, S.(1972).The effect of parathyroid hormone on hepatic cell transport of calcium.Endocrinology,90,663-672.
  10. Chausmer, A.B.,Stevens, M.D.,Zears, R.(1980).Influence of parathyroid hormone and calcitonin on tissue zine homeostasis in the rat.Metabolism,29,617-623.
  11. Chen, S.M.,Liao, J.F.,Kuo, C.D.,Ho, L.T.(2004).Intestinal absorption and biliary secretion of Line in rats with chronic renal failure.Nephron,96,113-120.
  12. Chen, S.M.,Young, T.K.,Ho, L.T.(1998).Effects of parathyroid hormone infusion on glucose tolerance and glucose-stimulated insulin secretion in normal and uremic rats.Diab. Res. Clin. Pract,41,85-94.
  13. Condon, C.H.,Freeman, R.M.(1970).Zinc metabolism in renal failure.Ann. Intern. Med.,73,531-536.
  14. Cousins, R.J.(1985).Absorption, transport and hepatic metabolism of copper and zinc: Special reference to metallothionein and ceruloplasmin.Physiol. Rev.,65,238-309.
  15. Cousins, R.J.,Dunn, M.A.,Leinart, A.S.,Yedinak, K.C.,DiSivestro, R.A.(1986).Coordinate regulation of line metabolism and metallothionein gene expression in rats.Am. J. Physiol,251,688-694.
  16. Cuajungco, M.P.,Lees, G.J.(1997).Zinc metabolism in the brain: relevance to human neurodegenerative disorders.Neurohiol. Dis.,4,137-169.
  17. Defronzo, R.A.,Sherwin, R.S.,Dillinghan, M.,Hendler, R.,Tamborlane, W.V.,Felig, P.(1978).Influence of basal insulin and glucagons secretion on potassium and sodium metabolism.J. Clin. Invest.,61,472-479.
  18. Dillaha, C.j.,Lorincz, A.L.,Aavik, O.R.(1953).Acrodermatitis enteropathica: Review of the literature and report of a case successfully treated with diodoquin.J. Am. Med. Assoc,152,509-512.
  19. Escohar-Morreale, H.F.,Rey, F.E.,Obregon, M.J.,Escobar, G.M.(1996).Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat.Endocrinology,137,2490-2502.
  20. Failla, M.L.,Cousins, R.J.(1978).Zinc accumulation and metabolism in primary cultures of rat liver cells: regulation by glucocorticoids.Biochim, Biophys. Acta,543,293-304.
  21. Fraser, C.L.,Sarnacki, P.(1988).Parathyroid homone-mediated changes in calcium transport in uremic rat brain synaptosomes.Am. J. Physiol,254,837-844.
  22. Gaciong, Z.,Alexiewicz, J.M.,Linker-Israeli, M.,Shulman, I.A.,Pitts, T.O.,Massry, S.G.(1991).Inhibition of immunoglobulin production by parathyroid hormone: Implication in chronic renal failure.Kidney Int.,40,96.
  23. Grey, A.,Mitnick, M.A.,Masiukiewicz, U.,Sun, B.H.,Rudikoff, S.,Jilka, R.L.,Manolagas, S.C.,Insogna, K.(1999).A role for interleukin6 in parathyroid hormone-induced bone resorption in vivo.Endocrinology,140,4683-4690.
  24. Haase, H.,Beyersmann, D.(2002).Intracellular zinc distribution and tranport in C6 rat glioma cells.Bioch. Bioph. Res. Comm.,296,923-928.
  25. Hirschberg, R.,Herrath, D.,Bosaller, W.,Mauelshagen, U.,Pauls, A.,Schaefer, K.(1985).Parathyroid hormone and 1, 25-dihydroxyvitamin D3 affect the tissue concentration of line in uremic rats.Nephron,39,277-279.
  26. Jastak, J.T.,Morrsion, A.B.,Raisz, L.G.(1968).Effect of renal insufficiency on parathyroid gland and calcium homeostasis.Am. J. Physiol,215,84-89.
  27. Karin, M.,Herschman, H.R.,Weinstein, D.(1980).Primary induction of metallothionein by dexamethasone in cultured rat hepatocytes.Biochim. Biophys. Res. Common,92,1052-1059.
  28. Kimmel, P.L.,Watkins, D.W.,Teller, E.B.,Khanna, R.,Dosa, S.,Phillip, T.M.(1988).Zinc balance in combined zinc deficiency and uremia.Kidney Int.,33,1091-1099.
  29. Lindeman, R.D.,Baxter, D.J.,Yunice, A.A.,Kraikitpanitch, S.(1978).Serum concentrations and urinary excretion of zinc in cirrhosis, nephritic syndrome and renal insufficiency.Am. J. Med. Sci.,275,17-31.
  30. Lindsay, Y.,Duthie, L.M.,MeArdle, H.J.(1994).Zinc levels in the rat fetal liver are not determined by transport across the placental microvillar membrane or the fetal liver plasma membrane.Biol. Reprod,51,358-365.
  31. Liuzzi, P.J.,Blanchard, R.K.,Cousins, R.J.(2001).Differential regulation of zinc transporter 1, 2, and 4 mRNA expression by dietary zinc in rats.J. Nutr.,131,46-52.
  32. Lowe, N.M.,Bremner, I.,Jackson, M.J.(1991).Plasma 65Zn kinetics in the rat.Brit. J. Nutr.,65,445-455.
  33. Mahajan, S.K.(1988).Zinc metabolism in uremia (Editorial).Int. J. Artif. Organs,11,228-233.
  34. Mahajan, S.K.,Bowersox, E.M.,Rye, D.L.,Abu Hamdan, D.K.,Prasad, A.S.,McDonald, F.D.,Biersack, K.L.(1989).Factors underlying abnormal zinc metabolism in uremia.Kidney Int.,27,269-273.
  35. Mahajan, S.K.,Gardiner, W.,Abbasi, A.A.(1978).Hypogeusia in patients on hemodialysis.Proc. Clin. Dial. Transplant Forum,8,20-24.
  36. Mahajan, S.K.,Prasad, A.S.,Rabbani, P.,Brigggs, W.A.,McDonald, F.D.(1979).Zinc metabolism in uremia..J. Lab. Clin. Med.,94,693-687.
  37. Mahajan, S.K.,Prasad, A.S.,Rabbani, P.,Briggs, W.A.,McDonald, F.D.(1982).Zinc deficiency: a reversible complication of uremia.Am. J. Clin. Nutr.,36,1177-1183.
  38. Mahler, D.J.,Walsh, J.R.,Haynie, G.D.(1971).Magnesium, zinc and copper in dialysis patients.Am. J. Clin. Path,56,17-23.
  39. Mansouri, K.,Halsted, J.A.,Gombos, E.A.(1970).Zinc, copper, magnesium and calcium in dialyzed and non-dialyzed uremic patients.Arch. Intern. Med.,125,88-93.
  40. Massry, S.G.(1983).The toxic effects of parathyroid hormone in uremia.Semin. Nephrol,3,306-326.
  41. Massry, S.G.,Coburn, J.W.,Popovtzer, M.M.,Shinaberger, J.H.,Maxwell, M.H.,Kleeman, C.R.(1969).Secondary hyperparathyroidism in chronic renal failure.Arch. Intern. Med.,124,431-441.
  42. Matsui, T.(1998).Zinc deficiency in Crohn`s disease.J. Gastroenterol,33,924-925.
  43. Onosaka, S.,Cherian, M.G.(1982).Comparison of metallothionein determination by polarographic and cadmium-saturation methods.Toxicol. Appl. Pharm,63,270-274.
  44. Pattison, S.E.,Cousins, R.J.(1986).Kinetics of zinc uptake and exchange by primary cultures of rat hepatocytes.Am. J. Physiol,250,677-685.
  45. Prasad, A.S.(2002).Zinc deficiency in patients with sickle cell disease.Am. J. Clin. Nutr.,75,181-182.
  46. Ranaldi, G.,Perozzi, G.,Truong-Tran, A.,Zalewski, P.,Murgia, C.(2002).Intracellular distribution of labile Zn(II) and zinc transporter expression in kidney and MDCK cells.Am. J. Physiol,283,1365-1375.
  47. Reyes, J.G.(1996).Zinc transport in mammalian cells.Am. J. Physiol,270,401-410.
  48. Scheuhammer, A.M.,Cherian, M.G.(1991).Quantification of metallothionein by silser saturation.Method Enzymol,205,78-83.
  49. Schroeder, J. J.,Cousins, R.J.(1990).Interleukin-6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures.Proc. Natl. Acad. Sci. USA,87,3137-3141.
  50. Sensi, S.L.,Yin, H.Z.,Carricdo, S.G.,Rao, S.S.,Weiss, J.H.(1999).Preferential Zn(superscript 2+) influx through Ca(superscript 2+)-permeable AMPA/Kainate channels triggers prolonged mitochondrial superoxide production.Proc. Natl. Acad. Sci. USA,96,2414-2419.
  51. Simons, T.J.B.(1991).Calcium-dependent zinc efflux in human red blood cells.J. Membrane Biol,123,73-82.
  52. Smythe, W.R.,Alfrey, A.C.,Craswell, P.W.,Crouch, C.A.,Ibels, L.S.,Kubo, H.,Nunnelley, L.L.,Rudolph, H.(1982).Trace element abnormalities in chronic uremia.Ann. Intern. Med.,96,302-310.
  53. Sugarman, A.,Kaji, D.M.,Stein, R.M.,Kahn, T.(1984).Extrarenal potassium transport and the β2-adrenergic system.J. Lab. Clin. Med.,103,912-921.
  54. Taylor, J.A.,Simons, T.J.B.(1994).The mechanism of zinc uptake by cultured rat liver cells.J. Physiol,474,55-64.
  55. Valberg, L.S.,Flanagan, F.P.R.,Ghent, C.N.,Chamberlain, M. J.(1985).Zinc absorption and leukocyte zinc in alcoholic and nonalcoholic cirrhosis.Dig. Dis. Sci.,30,329-333.
  56. Yunice, A.A.,King, R.W.,Kraikitpanitch, JrS.,Haygood, C.C.,Lindeman, R.D.(1978).Urinary zinc excretion following infusions of zinc sulfate, cysteine, histidine, or glycine.Am. J. Physiol,235,40-45.
  57. Zumkley, H.,Bertram, H.P.,Lison, A.,Knoll, O.,Losse, H.(1979).Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency.Clin. Nephrol,12,18-21.